Skip to main content
Alteogen Inc. logo

Alteogen Inc. — Investor Relations & Filings

Ticker · 196170 ISIN · KR7196170005 KO Professional, scientific and technical activities
Open in API
Filings indexed 293 across all filing types
Latest filing 2025-04-03 M&A Activity
Country KR South Korea
Listing KO 196170

About Alteogen Inc.

http://www.alteogen.com/

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Recent filings

Filing Released Lang Actions
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Alteogen) regarding the 'Decision to Acquire Shares and Securities of Another Corporation' (타법인주식및출자증권취득결정). This is a standard corporate disclosure filing in the Korean market (DART system) detailing an investment or acquisition activity. Since it involves the acquisition of shares in a subsidiary for corporate restructuring/merger purposes, it falls under the category of M&A activity or general corporate regulatory filings. Given the specific nature of the disclosure regarding the acquisition of shares in another entity, 'TAR' (M&A Activity) is the most appropriate classification.
2025-04-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details changes in share ownership by major shareholders and special related parties (directors/executives) of Alteogen. This type of filing is specifically designed to notify the market of significant changes in shareholding thresholds, which falls under the 'Major Shareholding Notification' category.
2025-04-03 Korean
정기주주총회결과
AGM Information Classification · 100% confidence The document is an official report of the results of an Annual General Meeting (AGM) for the company Alteogen. It details the approval of financial statements, board and auditor appointments, and other resolutions passed during the meeting held on 2025-03-31. This falls directly under the category of AGM Information (AGM-R).
2025-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange by Alteogen. It details the granting of stock options (주식매수선택권 부여) to directors and employees. This type of disclosure regarding share-based compensation and capital changes is classified under 'Share Issue/Capital Change' (SHA) as it pertains to the issuance of new shares or stock-related instruments.
2025-03-31 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming 'Corporate Presentation' (IR) event, specifically a Non-Deal Roadshow (NDR). It provides details such as the date, location, purpose, and target audience for the investor meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure of an upcoming investor relations activity.
2025-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Alteogen. It contains the auditor's opinion (적정/Unqualified), financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a specific regulatory filing required by the KRX (Korea Exchange) to announce the receipt and submission of the audit report, rather than the full 10-K annual report document itself. Therefore, it is classified as an Audit Report/Information document. FY 2024
2025-03-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.